Petrilli AA, Souza SJ, Teixeira AM, Pontilho PM, Souza JM, Luzia LA, et al
The letter was part of a broader March 2026 FDA sweep that named more than 30 telehealth companies over compounded GLP-1 marketing practices, so this was an industry-wide compliance issue rather than an isolated scandal
With the 2026 Standards of Care increasingly shifting the focus toward cardio-renal outcomes, many clinicians are asking: how far can we go safely with GLP1 receptor agonists in this population
Therefore, zinc-enriched vegan powders, particularly those with elevated zinc content, may offer important nutritional benefits for individuals adhering to plant-based diets
Licensed Peptides is not a compounding pharmacy or chemical compounding facility as defined by Section 503A of the Federal Food, Drug, and Cosmetic act.